2024

Sidley Healthcare Investment Conference

London

Agenda

10:00 a.m.

REGISTRATION AND NETWORKING BREAKFAST

11:00 a.m.

WELCOME

Robert Darwin, Partner, Private Equity and Life Sciences, Sidley (London)

OPENING REMARKS

Tom Thesing, Managing Partner, Sidley (London)

Junaid Bajwa, Senior Partner, Head of UK + Science Partner for Pioneering Intelligence, Flagship Pioneering

Simone Fishburn, Vice President and Editor-in-Chief, BioCentury

11:25 a.m.

PHARMA BUSINESS DEVELOPMENT – SENIOR BD AND BIOTECH FIGURES DEBATE THE M&A, LICENSING, AND COLLABORATION CLIMATE. WHICH THERAPEUTIC AREAS AND GEOGRAPHIES ARE GARNERING THE MOST ATTENTION?

MODERATOR: Asher Rubin, Partner, Technology and Life Sciences Transactions, Sidley (Baltimore)

SPEAKERS:

Caroline Austin, Vice President, Head of Transactions, Business Development, AstraZeneca

Susan Hill, CEO, Mestag Therapeutics

Guillaume Vignon, Global Head BD&L Transactions, Novartis

‍12:10 p.m.

“A LIFE IN PHARMA AND PIVOTING TO INNOVATION”

MODERATOR: Robert Darwin, Partner, Private Equity and Life Sciences, Sidley (London)

SPEAKER:

Richard Francis, President and CEO, Teva

1:00 p.m.

NETWORKING LUNCH

2:10 p.m.

PRIVATE EQUITY – WHAT IS THE OUTLOOK FOR PE INVESTMENT ACTIVITY ACROSS HEALTHCARE AND LIFE SCIENCES? WHICH DOMAINS WILL BE THE “WINNERS”?

MODERATOR: Annalisa Jenkins, Bio Pharma Thought Leader and Non-Executive Director, Compass Pathways

SPEAKERS:

Tony Drabble, Senior Principal, IQVIA

Andrea Pelliccia, Principal, LetterOne Health

Sharon Spangenberg, Senior Principal, Onex Partners

Dimitrios Tzivelis, Healthcare Investor, Permira

‍3:00 p.m.

‍ARTIFICIAL INTELLIGENCE – TO WHAT EXTENT, AND WHERE, DOES AI REPRESENT AN INVESTMENT OPPORTUNITY ACROSS HEALTHCARE AND LIFE SCIENCES?

MODERATOR: Francesca Blythe, Partner, Privacy and Cybersecurity, Sidley (London)

SPEAKERS:

Dr. Hutan Ashrafian MD, PhD, MBA, Chief Scientific Officer, Preemptive Medicine and Health Security, Flagship Pioneering

Keri Hildick PhD, Chief Strategy Officer, Perspectum

Edward Kliphuis, Partner, Sofinnova Partners

Dr. Umang Patel, Chief Clinical Information Officer, Microsoft

3:50 p.m.

BREAK AND NETWORKING

‍4:40 p.m.

A VIEW FROM THE BANKS – OPINIONS, INSIGHTS, AND PREDICTIONS ON THE MARKET FROM THE LEADING GLOBAL HEALTHCARE DEALMAKERS

MODERATOR: Ian Johnston, Acting Global Pharmaceutical Correspondent, Financial Times

SPEAKERS:

Alberto Bertani, Managing Director, Global Healthcare Team, Morgan Stanley

Stefano Beschi, Partner, Rothschild & Co.

James Mitford, Managing Director, J.P. Morgan

Dr. Zahid Moneer, Senior Managing Director, BNP Paribas

‍5:30 p.m.

‍VENTURE/GROWTH CAPITAL – HOW ARE GLOBAL FUNDS INVESTING IN A MORE MUTED MARKET? HOW DO INVESTEES STAND OUT? VIEWS FROM LEADING GLOBAL LIFE SCIENCES INVESTORS

MODERATOR: Frank Rahmani, Partner, Emerging Companies and Venture Capital, Sidley (Palo Alto)

SPEAKERS:

Maina Bhaman, Partner, Sofinnova Partners

Roel Bulthuis, Managing Partner, Syncona Limited

Tim Funnell, Partner, DPhil, BS, Monograph Capital Partners

Dr. Ruth McKernan CBE, PhD, Venture Partner, SV Health Investors

6:20 p.m.

CLOSING REMARKS

Fred Cohen, Partner and Chairman, MD, DPhil, Monograph Capital Partners

6:30 p.m. – 8:00 p.m.

NETWORKING DRINKS AND CANAPÉS RECEPTION

Speakers

Dr. Hutan Ashrafian MD, PhD, MBA

Dr. Hutan Ashrafian MD, PhD, MBA

Founder and CEO, Flagship Pioneering and Co-Founder and Chairman, Moderna

Catherine Austin

Caroline Austin

Vice President, Head of Transactions, Business Development

Junaid Bajwa

Junaid Bajwa

Senior Partner, Head of UK +Science Partner for Pioneering Intelligence

Alberto Bertani

Alberto Bertani

Managing Director, GlobalHealthcare Team

Morgan Stanley

Stefano Beschi

Stefano Beschi

Partner

Maina Bhaman

Maina Bhaman

Partner

Soffinova Partners

Francesca Blythe

Francesca Blythe

Partner

Sidley

Roel Bulthuis

Roel Bulthuis

Partner

Sycona

Fred Cohen

Fred Cohen

Partner and Chairman, MD, DPhil

Monograph Capital

Robert Darwin

Robert Darwin

Partner

Sidley

Tony Drabble

Senior Principal

Simone Fishburn

Simone Fishburn

Partner and Leader of Global Life Sciences Practice

BioCentury

Richard Francis

Richard Francis

Chief Executive Officer

Tim Funnell

Tim Funnell

Partner, DPhil, BS

Monograph Capital

Dr. Keri Hildick PhD

Dr. Keri Hildick PhD

Executive Vice President, Business Development

Perspectum

Susan Hill

Susan Hill

CEO

MESTAG Therapeutics

Annalisa Jenkins

Annalisa Jenkins

BioPharma Thought Leader & Non-Executive Director

Compass

Ian Johnston

Ian Johnston

Acting Global Pharmaceutical Correspondent

Financial Times

Edward Kliphuis

Edward Kliphuis

Partner

Soffinova Partners

Ruth McKernan CBE, PhD

Ruth McKernan CBE, PhD

Venture Partner

James Mitford

James Mitford

Managing Director

J.P. Morgan

Dr. Zahid Moneer

Dr. Zahid Moneer

Senior Managing Director

Dr. Umang Patel

Dr. Umang Patel

Chief Clinical Information Officer

Microsoft

Andrea Pelliccia

Andrea Pelliccia

Principal

Frank Rahmani

Frank Rahmani

Partner

Sidley

Thomas Thesing

Asher Rubin

Partner

Sidley

Sharon Spangenberg

Sharon Spangenberg

Senior Principal

Thomas Thesing

Thomas Thesing

Partner

Sidley

Dimitrios Tzivelis

Dimitrios Tzivelis

Healthcare Investor

Permira

Guillaume Vignon

Guillaume Vignon

Global Head BD&L Transactions

Novartis

Resources

AI and Digital Health Trends: Innovative Financing Structures Seek To Mitigate AI Healthcare Investment Risks

Investor Attitudes to Healthcare AI Technologies

Key Regulatory and Compliance Considerations
for Early-Stage Life Sciences Companies and Their Investors

Sidley Global Life Sciences LinkedIn Page

How to Secure Investment as a Healthcare AI Innovator

Sidley GoodLifeSci Blog

In partnership with: